» Authors » Carla Jevoux

Carla Jevoux

Explore the profile of Carla Jevoux including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 70
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Krymchantowski A, Jevoux C, Piovesan E, Valenca M, Kowacs F, Kowacs P, et al.
J Headache Pain . 2024 Dec; 25(1):211. PMID: 39627689
Objective: To present the first Brazilian real-world results with galcanezumab and provide a consensus expert opinion on the prophylactic treatment of cluster headache (CH) in Brazil. Methods: The first part...
2.
Silva-Neto R, de Almeida Soares A, de Oliveira Souza W, Leodido Fortes Y, Lopes L, Krymchantowski A, et al.
Postgrad Med . 2024 Nov; 137(1):54-59. PMID: 39604134
Background: Migraine is a recurrent headache disorder characterized by moderate to severe, throbbing pain, typically unilateral. It can be classified as migraine with or without aura, depending on the presence...
3.
Krymchantowski A, Jevoux C, Krymchantowski A, Dominguez-Moreno R, Silva-Neto R
Cureus . 2024 Oct; 16(10):e72347. PMID: 39463910
Background: Medication overuse headache (MOH) is one of the global health-related problems that imposes significant morbidity. Effective management requires the abrupt cessation of the overused medications, transition therapy in the...
4.
Krymchantowski A, Jevoux C, Krymchantowski A, Ramos L, Barbosa J, Silva-Neto R
Front Pain Res (Lausanne) . 2023 Oct; 4:1103497. PMID: 37881687
Medication-overuse headache (MOH) can develop from primary headaches. MOH is usually the result of overuse of symptomatic medications. It is a noteworthy personal and societal burden. The identification and treatment...
5.
Krymchantowski A, Jevoux C, Krymchantowski A, Silva-Neto R
Clin Neuropharmacol . 2023 Sep; 46(5):181-185. PMID: 37748000
Objective: Medication overuse headache (MOH) in chronic migraineurs may be a cause or consequence of the overuse of symptomatic medications for headache attacks. It is highly prevalent in tertiary centers....
6.
Silva-Neto R, de Almeida Soares A, de Oliveira Souza W, Krymchantowski A, Jevoux C, Krymchantowski A
Headache . 2023 Sep; 63(8):1070-1075. PMID: 37671464
Background: Children and adolescents may experience pain in the lower limbs, predominantly at the end of the day or during the night, without any relation to organic disease. These pains...
7.
Krymchantowski A, Jevoux C, Krymchantowski A, Silva-Neto R
Front Neurol . 2023 Mar; 14:1129439. PMID: 36937507
Background: Medication-overuse headache is highly prevalent in tertiary care centers. It may be a cause or consequence of the overuse of symptomatic medications for migraine attacks. Objective: We aimed to...
8.
Jevoux C, Krymchantowski A, Silva-Neto R, Cotrik E, Nardi A, Gomes J, et al.
J Med Cases . 2022 Dec; 13(11):525-529. PMID: 36506757
Neuropsychiatric disorders associated with coronavirus infections emerged with the coronavirus disease 2019 (COVID-19) pandemic. We describe the clinical, laboratory and radiological features of a patient who presented, after recent COVID-19,...
9.
Krymchantowski A, Silva-Neto R, Jevoux C, Krymchantowski A
Postgrad Med . 2022 May; 134(6):598-602. PMID: 35584542
Background: Migraine is a highly disabling and prevalent neurological disorder. A peptide, calcitonin gene-related peptide, was identified as involved in migraine pathophysiology and monoclonal anti-CGRP antibodies have been developed. Aim:...
10.
Krymchantowski A, Silva-Neto R, Jevoux C, Krymchantowski A
Acta Neurol Belg . 2021 Sep; 122(2):465-469. PMID: 34546559
Background: COVID-19, a disease caused by SARS-CoV-2, manifests with headache, both in the acute phase and as a post-infection symptom, which may be refractory to usual analgesics. Objectives: Investigate the...